Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice
Open Access
- 5 December 2014
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 12 (1) , 344
Abstract
Endometrial regenerative cells (ERCs) are mesenchymal-like stem cells that can be non-invasively obtained from menstrual blood and are easily grown /generated at a large scale without tumorigenesis. We previously reported that ERCs exhibit unique immunoregulatory properties in vitro, however their immunosuppressive potential in protecting the colon from colitis has not been investigated. The present study was undertaken to determine the efficacy of ERCs in mediating immunomodulatory functions against colitis. Colitis was induced by 4% dextran-sulfate-sodium (DSS, in drinking water) in BALB/c mice for 7 days. ERCs were cultured from healthy female menstrual blood, and injected (1 million/mouse/day, i.v.) into mice on days 2, 5, and 8 following colitis induction. Colonic and splenic tissues were collected on day 14 post-DSS-induction. Clinical signs, disease activity index (DAI), pathological and immunohistological changes, cytokine profiles and cell populations were evaluated. DSS-induced mice in untreated group developed severe colitis, characterized by body-weight loss, bloody stool, diarrhea, mucosal ulceration and colon shortening, as well as pathological changes of intra-colon cell infiltrations of neutrophils and Mac-1 positive cells. Notably, ERCs attenuated colitis with significantly reduced DAI, decreased levels of intra-colon IL-2 and TNF-α, but increased expressions of IL-4 and IL-10. Compared with those of untreated colitis mice, splenic dendritic cells isolated from ERC-treated mice exhibited significantly decreased MHC-II expression. ERC-treated mice also demonstrated much less CD3+CD25+ active T cell and CD3+CD8+ T cell population and significantly higher level of CD4+CD25+Foxp3+ Treg cells. This study demonstrated novel anti-inflammatory and immunosuppressive effects of ERCs in attenuating colitis in mice, and suggested that the unique features of ERCs make them a promising therapeutic tool for the treatment of ulcerative colitis.Keywords
This publication has 63 references indexed in Scilit:
- Effects of Interleukin-4 or Interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitisBMC Gastroenterology, 2013
- Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinicJournal of Translational Medicine, 2013
- Immunomodulatory Effects of Mesenchymal Stromal Cells in Crohn’s DiseaseJournal of Allergy, 2012
- Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answersImmunology, 2012
- How mesenchymal stem cells interact with tissue immune responsesTrends in Immunology, 2012
- Mesenchymal stem cells impair in vivo T-cell priming by dendritic cellsProceedings of the National Academy of Sciences, 2011
- Menstrual Blood Cells Display Stem Cell–Like Phenotypic Markers and Exert Neuroprotection Following Transplantation in Experimental StrokeStem Cells and Development, 2010
- The role of T‐regulatory cells and Toll‐like receptors in the pathogenesis of human inflammatory bowel diseaseImmunology, 2008
- Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia?Journal of Translational Medicine, 2008
- Endometrial regenerative cells: A novel stem cell populationJournal of Translational Medicine, 2007